Ajanta Pharma Buyback 2021
(i) Ajanta Pharma is a specialty pharmaceutical company engaged in the development, manufacturing, and marketing of quality finished dosages. Committed to ‘Serve Health Care Needs Worldwide’, they produce a comprehensive range of specialty products targeting different therapeutic segments for the treatment of patients, customized to each market.
(ii) Their business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.
(iii) The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia. In India, they have a presence in high growth specialty segments of cardiology, dermatology, ophthalmology and pain management where they have been able to provide consistently innovative products, many being 1st to the market, for patient convenience and compliance.
Buy Back Offer Deal:
|Buyback Type:||Tender Offer|
|Buyback Record Date:||Jan 14 2022|
|Buyback Opening Date:||Feb 03 2022|
|Buyback Closing Date:||Feb 16 2022|
|Buyback Offer Amount:||₹ 285.60 Cr|
|Date of Board Meeting approving the proposal:||Dec 28 2021|
|Date of Public Announcement:||Dec 28 2021|
|Buyback Offer Size:||1.29%|
|Buyback Number of Shares:||11,20,000|
|Price Type:||Tender Offer|
|Buyback Price:||₹ 2550 Per Equity Share|
Details of Buyback:
Salient financial parameters:
|Profit before tax||456||559||648||623||514||664||900|
|EPS in Rs||35.25||47.23||57.59||53.25||44.35||53.6||75.56|
|Dividend Payout %||17%||17%||23%||0%||20%||24%||13%|
How to Participate in buyback?
Profit from the buyback on the bases of acceptance Ratio:
|Amount Invested in Buyback||1,76,592||1,76,592||1,76,592||1,76,592|
|No. of Shares buyback||25||39||59||78|